Family planning and pregnancy issues for women with systemic inflammatory diseases: patient and physician perspectives. Issue 2 (5th February 2014)

• Record Type: Journal Article
• Authors: Chakravarty, Eliza; Clowse, Megan E B; Pushparajah, Daphnee S; Mertens, Sarah; Gordon, Caroline
• Is Part Of: BMJ open. Volume 4:Issue 2(2014)
• Publication Date: 2014-02-05
• Subjects: Pregnancy -- Autoimmune disease -- Inflammatory disease -- Family Planning; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2013-004081
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Objectives: To identify family planning and pregnancy (FPP) issues for female patients of childbearing age living with a chronic inflammatory disease and to assess whether current clinical practice routinely provides adequate support to alleviate these concerns. Setting: Multinational survey and an analysis of online patient activity. Participants: Premenopausal women (aged 20–45 years; N=969) were surveyed in the USA, the UK, Germany, France, Italy and Spain. Rheumatologists were surveyed in Germany (N=50), France (N=50), Italy (N=50) and the USA (N=100), and gastroenterologists were also surveyed in the USA (N=100). Primary and secondary outcome measures: Two online surveys were undertaken to identify FPP issues for physicians and patients. The surveys examined the frequency of dialogue on these topics between physicians and patients, alongside assessment of patient satisfaction regarding these conversations. Online analysis identified key themes for patient discussion outside their doctors' office/clinic/surgery. Results: 32–56% of physicians spontaneously reported having talked about FPP with their female patients of childbearing age. When prompted, the majority of rheumatologists (74–92%) and gastroenterologists (74%) reported having discussed conception/pregnancy with female patients; however, less than half reported consulting their patient's treating general practitioner/gynaecologist about these topics. The majority of patients reported their FPP-related concerns are not adequately addressed/settled during their medical appointments. Furthermore, only 30–40% of patients considered advice/information to be consistent across multiple healthcare professionals. Key online FPP-related patient discussions included disease state, adverse effects, treatment, switch behaviour and wash-out requirements. Conclusions: Female patients who live with chronic inflammatory disease have important FPP concerns. The majority of patients, however, do not feel that their FPP concerns are adequately addressed in current clinical practice and report that they receive inconsistent advice from the various healthcare professionals who manage different aspects of their care. There is a clear need for provision of up-to-date and consistent information/support to female patients.